Tongdao Liepin Group
HKEX:6100
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tongdao Liepin Group
HKEX:6100
|
CN |
|
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999
|
CN |
Income Statement
Earnings Waterfall
Tongdao Liepin Group
Income Statement
Tongdao Liepin Group
| Dec-2018 | Jun-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||
| Interest Expense |
2
|
0
|
6
|
0
|
0
|
0
|
9
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
7
|
0
|
0
|
|
| Revenue |
1 225
N/A
|
1 359
+11%
|
1 513
+11%
|
1 467
-3%
|
1 220
-17%
|
1 674
+37%
|
1 870
+12%
|
2 050
+10%
|
2 260
+10%
|
2 488
+10%
|
2 651
+7%
|
2 777
+5%
|
2 825
+2%
|
2 784
-1%
|
2 638
-5%
|
2 492
-6%
|
2 359
-5%
|
2 277
-3%
|
2 282
+0%
|
2 250
-1%
|
2 204
-2%
|
2 148
-3%
|
2 081
-3%
|
2 004
-4%
|
1 986
-1%
|
|
| Gross Profit | ||||||||||||||||||||||||||
| Cost of Revenue |
(238)
|
(285)
|
(346)
|
(321)
|
(280)
|
(378)
|
(413)
|
(458)
|
(496)
|
(552)
|
(584)
|
(607)
|
(626)
|
(614)
|
(591)
|
(582)
|
(575)
|
(567)
|
(586)
|
(572)
|
(538)
|
(521)
|
(498)
|
(485)
|
(464)
|
|
| Gross Profit |
988
N/A
|
1 074
+9%
|
1 168
+9%
|
1 146
-2%
|
939
-18%
|
1 295
+38%
|
1 457
+12%
|
1 592
+9%
|
1 765
+11%
|
1 936
+10%
|
2 067
+7%
|
2 170
+5%
|
2 198
+1%
|
2 170
-1%
|
2 047
-6%
|
1 910
-7%
|
1 784
-7%
|
1 709
-4%
|
1 696
-1%
|
1 678
-1%
|
1 666
-1%
|
1 626
-2%
|
1 583
-3%
|
1 518
-4%
|
1 522
+0%
|
|
| Operating Income | ||||||||||||||||||||||||||
| Operating Expenses |
(1 051)
|
(1 064)
|
(1 129)
|
(1 052)
|
(846)
|
(1 131)
|
(1 368)
|
(1 438)
|
(1 583)
|
(1 722)
|
(1 889)
|
(1 921)
|
(1 881)
|
(1 833)
|
(1 998)
|
(1 889)
|
(1 866)
|
(1 865)
|
(1 788)
|
(1 621)
|
(1 572)
|
(1 506)
|
(1 513)
|
(1 342)
|
(1 344)
|
|
| Selling, General & Administrative |
(925)
|
(959)
|
(971)
|
(996)
|
(787)
|
(1 038)
|
(1 169)
|
(1 276)
|
(1 403)
|
(1 518)
|
(1 580)
|
(1 648)
|
(1 612)
|
(1 555)
|
(1 651)
|
(1 585)
|
(1 583)
|
(1 604)
|
(1 462)
|
(1 435)
|
(1 372)
|
(1 328)
|
(1 224)
|
(1 155)
|
(1 175)
|
|
| Research & Development |
(138)
|
(170)
|
(185)
|
(187)
|
(164)
|
(219)
|
(240)
|
(186)
|
(199)
|
(228)
|
(337)
|
(357)
|
(378)
|
(390)
|
(400)
|
(399)
|
(386)
|
(377)
|
(360)
|
(353)
|
(351)
|
(332)
|
(304)
|
(269)
|
(272)
|
|
| Other Operating Expenses |
13
|
65
|
27
|
131
|
105
|
127
|
41
|
24
|
19
|
24
|
28
|
84
|
109
|
112
|
53
|
95
|
102
|
116
|
34
|
167
|
151
|
154
|
16
|
82
|
103
|
|
| Operating Income |
(63)
N/A
|
10
N/A
|
39
+290%
|
93
+141%
|
93
+0%
|
165
+77%
|
89
-46%
|
154
+72%
|
182
+18%
|
214
+18%
|
178
-17%
|
249
+39%
|
317
+28%
|
337
+6%
|
49
-85%
|
21
-57%
|
(82)
N/A
|
(156)
-91%
|
(92)
+41%
|
58
N/A
|
94
+63%
|
120
+28%
|
70
-41%
|
176
+151%
|
178
+1%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||
| Interest Income Expense |
74
|
63
|
93
|
18
|
13
|
(9)
|
20
|
(39)
|
(54)
|
(32)
|
39
|
(21)
|
4
|
23
|
60
|
19
|
16
|
(7)
|
124
|
2
|
(11)
|
(17)
|
121
|
47
|
(28)
|
|
| Non-Reccuring Items |
0
|
0
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Total Other Income |
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
(1)
|
0
|
|
| Pre-Tax Income |
10
N/A
|
72
+606%
|
141
+96%
|
111
-21%
|
107
-4%
|
155
+45%
|
108
-30%
|
115
+6%
|
128
+11%
|
182
+42%
|
215
+18%
|
228
+6%
|
321
+41%
|
360
+12%
|
108
-70%
|
40
-62%
|
(66)
N/A
|
(163)
-148%
|
30
N/A
|
60
+102%
|
83
+39%
|
103
+24%
|
190
+85%
|
222
+17%
|
153
-31%
|
|
| Net Income | ||||||||||||||||||||||||||
| Tax Provision |
(7)
|
(4)
|
(15)
|
(6)
|
(4)
|
(7)
|
(15)
|
(17)
|
(22)
|
(33)
|
(23)
|
(26)
|
(25)
|
(25)
|
(18)
|
(12)
|
(16)
|
(6)
|
(13)
|
(8)
|
(13)
|
(13)
|
(14)
|
(10)
|
(12)
|
|
| Income from Continuing Operations |
3
|
68
|
127
|
105
|
103
|
148
|
93
|
98
|
106
|
149
|
191
|
202
|
296
|
335
|
90
|
28
|
(82)
|
(169)
|
17
|
52
|
70
|
89
|
175
|
212
|
141
|
|
| Income to Minority Interest |
5
|
4
|
(6)
|
(14)
|
(33)
|
(45)
|
(39)
|
(40)
|
(33)
|
(35)
|
(57)
|
(63)
|
(73)
|
(72)
|
(45)
|
(22)
|
(8)
|
(3)
|
(16)
|
(19)
|
(32)
|
(38)
|
(42)
|
(44)
|
(38)
|
|
| Net Income (Common) |
8
N/A
|
72
+835%
|
120
+66%
|
91
-24%
|
70
-23%
|
103
+47%
|
54
-48%
|
58
+8%
|
73
+26%
|
115
+57%
|
134
+17%
|
139
+3%
|
223
+61%
|
263
+18%
|
44
-83%
|
6
-87%
|
(90)
N/A
|
(172)
-92%
|
1
N/A
|
33
+4 305%
|
38
+14%
|
52
+37%
|
133
+158%
|
168
+26%
|
103
-39%
|
|
| EPS (Diluted) |
0.02
N/A
|
0.13
+550%
|
0.23
+77%
|
0.17
-26%
|
0.13
-24%
|
0.2
+54%
|
0.1
-50%
|
0.11
+10%
|
0.14
+27%
|
0.22
+57%
|
0.26
+18%
|
0.27
+4%
|
0.45
+67%
|
0.52
+16%
|
0.09
-83%
|
0.01
-89%
|
-0.18
N/A
|
-0.33
-83%
|
0
N/A
|
0.06
N/A
|
0.07
+17%
|
0.1
+43%
|
0.28
+180%
|
0.34
+21%
|
0.21
-38%
|
|